Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 62135-503

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 62135-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Rabeprazole Sodium Fig 2)

This text appears to be a table showing the number of participants (n) in a medical study for three different groups: placebo (with 68 participants), RAB 10mg (with 64 participants), and RAB 20mg (with 67 participants). It is likely that RAB refers to some medication or treatment, but without further context, it is unclear what it is.*

FDA Label Image

Image Description (Rabeprazole Sodium Fig 3)

FDA Label Image

Image Description (Rabeprazole Sodium Fig 4)

This appears to be a chart or a form used to record scores for the severity of a condition. It uses a scale from 0 to 4 to rate the severity, with 0 being the absence of any symptoms and 4 being the most severe. However, it is not clear what the condition being scored is as the text is too limited.*

FDA Label Image

Image Description (Rabeprazole Sodium Fig 5)

FDA Label Image

Image Description (Rabeprazole Sodium Tablets Label)

FDA Label Image

Image Description (Raberazole Sodium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.